204 related articles for article (PubMed ID: 16001646)
1. Upper gastrointestinal disorders induced by non-steroidal anti-inflammatory drugs.
Chiba T; Sato K; Endo M; Ando T; Inomata M; Orii S; Suzuki K
Hepatogastroenterology; 2005; 52(64):1134-8. PubMed ID: 16001646
[TBL] [Abstract][Full Text] [Related]
2. Upper gastrointestinal disorders induced by non-steroidal anti-inflammatory drugs.
Chiba T; Sato K; Kudara N; Shinozaki H; Ikeda K; Sato K; Endo M; Orii S; Suzuki K
Inflammopharmacology; 2008 Feb; 16(1):16-20. PubMed ID: 18256801
[TBL] [Abstract][Full Text] [Related]
3. Endoscopic characteristics and Helicobacter pylori infection in NSAID-associated gastric ulcer.
Kamada T; Hata J; Kusunoki H; Sugiu K; Tanimoto T; Mihara M; Hamada H; Kido S; Dongmei Q; Haruma K
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):98-102. PubMed ID: 16706819
[TBL] [Abstract][Full Text] [Related]
4. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
Goldstein JL; Aisenberg J; Lanza F; Schwartz H; Sands GH; Berger MF; Pan S
Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449
[TBL] [Abstract][Full Text] [Related]
5. Variations in the risk of gastrointestinal hemorrhage with non-steroidal anti-inflammatory drugs and localization of lesions.
Pulanić R; Dubravcić D; Ostojić-Pulanić B; Vrhovac B
Acta Med Croatica; 1998; 52(2):91-8. PubMed ID: 9682495
[TBL] [Abstract][Full Text] [Related]
6. [Development and relapse of gastroduodenal ulcer in patients taking nonsteroid anti-inflammatory drugs: effects of standard risk factors].
Karateev AE; Nasonova VA
Ter Arkh; 2008; 80(5):62-6. PubMed ID: 18590118
[TBL] [Abstract][Full Text] [Related]
7. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
[TBL] [Abstract][Full Text] [Related]
8. Decreasing incidence of symptomatic gastrointestinal ulcers and ulcer complications in patients with rheumatoid arthritis.
Steen KS; Nurmohamed MT; Visman I; Heijerman M; Boers M; Dijkmans BA; Lems WF
Ann Rheum Dis; 2008 Feb; 67(2):256-9. PubMed ID: 17604285
[TBL] [Abstract][Full Text] [Related]
9. [The effect of non-steroidal anti-inflammatory drugs on upper gastrointestinal disorders in orthopaedic patients].
Uchio Y; Mori R; Iwasa J; Kakimaru H; Yamamoto S; Yamaguchi H; Miyamoto W
Nihon Rinsho; 2007 Oct; 65(10):1906-11. PubMed ID: 17926545
[TBL] [Abstract][Full Text] [Related]
10. [Present position in the prevention and therapy of NSAID-induced ulcers].
Lehmann FS; Beglinger C
Schweiz Med Wochenschr; 1999 Jul; 129(29-30):1073-80. PubMed ID: 10464910
[TBL] [Abstract][Full Text] [Related]
11. Effect of gastric mucosal protection in nonrheumatoid patients with short-term nonsteroidal anti-inflammatory drug therapy: a prospective randomized multicenter study.
Miller K
Hepatogastroenterology; 1997; 44(15):872-9. PubMed ID: 9222707
[TBL] [Abstract][Full Text] [Related]
12. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol.
Koch M
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S54-62. PubMed ID: 10379471
[TBL] [Abstract][Full Text] [Related]
13. Effects of nonsteroidal anti-inflammatory drugs on endogenous gastrointestinal prostaglandins and therapeutic strategies for prevention and treatment of nonsteroidal anti-inflammatory drug-induced damage.
Cryer B; Feldman M
Arch Intern Med; 1992 Jun; 152(6):1145-55. PubMed ID: 1599341
[TBL] [Abstract][Full Text] [Related]
14. The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor.
Goldstein JL; Lowry SC; Lanza FL; Schwartz HI; Dodge WE
Aliment Pharmacol Ther; 2006 May; 23(10):1489-98. PubMed ID: 16669964
[TBL] [Abstract][Full Text] [Related]
15. An endoscopic study of gastroduodenal lesions induced by nonsteroidal anti-inflammatory drugs.
Cheatum DE; Arvanitakis C; Gumpel M; Stead H; Geis GS
Clin Ther; 1999 Jun; 21(6):992-1003. PubMed ID: 10440623
[TBL] [Abstract][Full Text] [Related]
16. Upper gastrointestinal lesions in elderly patients presenting for endoscopy: relevance of NSAID usage.
Bellary SV; Isaacs PE; Lee FI
Am J Gastroenterol; 1991 Aug; 86(8):961-4. PubMed ID: 1858761
[TBL] [Abstract][Full Text] [Related]
17. Acute NSAID-related transmural duodenitis and extensive duodenal ulceration.
Hashash JG; Atweh LA; Saliba T; Chakhachiro Z; Al-Kutoubi A; Tawil A; Barada KA
Clin Ther; 2007 Nov; 29(11):2448-52. PubMed ID: 18158085
[TBL] [Abstract][Full Text] [Related]
18. Influence of COX-2 and local cytokine expressions in gastric ulcer mucosa by H. pylori and NSAID.
Wu CY; Wu MS; Chen YJ; Chen CJ; Lin JT; Chen GH
Hepatogastroenterology; 2006; 53(71):797-803. PubMed ID: 17086892
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced upper gastrointestinal disorders requiring hospitalization: a five-year study in a South Indian hospital.
Devi DP; Sushma M; Guido S
Pharmacoepidemiol Drug Saf; 2004 Dec; 13(12):859-62. PubMed ID: 15386699
[TBL] [Abstract][Full Text] [Related]
20. Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications.
Goldstein JL; Howard KB; Walton SM; McLaughlin TP; Kruzikas DT
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1337-45. PubMed ID: 17088110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
